Search clinical trials for: cytokine adsorber (CytoSorb®)

Total 419 results

University of Giessen
Deutsche Stiftung für Herzforschung

Recruiting

Removal Of CytoKines With cytoSorbenTs After Inflammatory Response Reaction During Cardiac Surgery (ROCKSTAR)

Inflammatory Response

Germany
Dr. Alexander Supady

Completed

Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation (CYCOV)

COVID-19 | Respiratory Failure | SARS-CoV Infection | Coronavirus | Cytokine Storm

Germany
Dr. Alexander Supady
Ludwig-Maximilians - University of Munich; University of Ulm; Klinikum Ibbenbüren and other collaborators

Suspended

Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation (CYCOV-II)

Coronavirus Infection | SARS-CoV 2 | Respiratory Failure | Extracorporeal Membrane Oxygenation | COVID | Cytokine Storm

Germany
Dr. Alexander Supady

Recruiting

Cytokine Adsorption in Acute-on-chronic Liver Failure (CYTOHEP)

Acute-On-Chronic Liver Failure | Renal Failure

Germany
Klinikum Nürnberg
CytoSorbents, Inc

Unknown

Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPB (REMOTE)

Extracorporeal Circulation | Hemofiltration

Germany
Medical University of Vienna

Recruiting

Haemoadsorption During Heart Transplantation (CytoSorbHTX)

Heart Transplantation

Austria
Jena University Hospital
University Hospital Goettingen

Unknown

International Registry on the Use of the CytoSorb Adsorber (CytoSorb)

Sepsis | Need of Cardiac Surgery

Germany, Hungary, Austria
University of Rostock

Unknown

Use of Extracorporeal Treatment With the Cytosorb-Adsorber for the Reduction of SIRS in Heart Surgery Patients (CASHSP)

Multiple Organ Failure

Germany
National Research Center for Cardiac Surgery, Kazakhstan
Ministry of Education and Science, Republic of Kazakhstan

Recruiting

Innovative Technologies for the Treatment of Pulmonary and Heart Failure

Sepsis | Multiple Organ Failure | Decompensated Heart Failure | Ventricular Arrythmia | Pulmonary Failure | Cardiogenic Shock | Acute Heart Failure | Cardiac Arrest With Successful Resuscitation

Kazakhstan
University of Zurich
CytoSorbents Europe GmbH

Completed

Cytokine Adsorption in Severe, Refractory Septic Shock

Septic Shock | Cytokine Storm
Universitätsklinikum Hamburg-Eppendorf

Completed

Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery

Coronary Artery Disease | Heart Valve Diseases

Germany
University of Pecs

Suspended

Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial (DECRISS)

Septic Shock

Hungary
National Research Center for Cardiac Surgery, Kazakhstan
Ministry of Education and Science, Republic of Kazakhstan

Recruiting

Organ-substituting Technologies in the Treatment of Heart and Pulmonary Failure (OST)

Sepsis | Septic Shock | Acute Respiratory Distress Syndrome

Kazakhstan
Christian Schulze

Recruiting

ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock (ECMOsorb)

Cardiogenic Shock

Germany
Jena University Hospital
German Federal Ministry of Education and Research; CytoSorbents, Inc; Thermo... and other collaborators

Completed

Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis (REMOVE)

Infective Endocarditis

Germany
Papa Giovanni XXIII Hospital

Recruiting

HOPE With Cytokine Filtration in Liver Transplantation (Cyto-HOPE) (Cyto-HOPE)

Liver Transplantation | Early Allograft Dysfunction | Post-Reperfusion Syndrome | Ischaemia-Reperfusion Injury

Italy
Research Institute for Complex Problems of Cardiovascular...

Completed

Myeloid-Derived Supressor Cells in Cardiac Surgery Patients (MyDeCCS)

Systemic Inflammatory Response Syndrome | Insufficiency; Cardiac, Complicating Surgery

Russian Federation
Semmelweis University

Completed

Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation

Cardiopulmonary Bypass | Cardiac Transplantation

Hungary
Universitätsklinikum Hamburg-Eppendorf
CytoSorbents, Inc

Terminated

Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy (EXCESS)

Inflammation

Germany
Centre Hospitalier Universitaire Vaudois

Completed

Hemoadsorption With CytoSorb® in Post-Cardiac Arrest Syndrome (CATCH)

Cardiac Arrest

Switzerland
CytoSorbents Europe GmbH
BRAHMS GmbH; MedInnovation GmbH

Recruiting

A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock (PROCYSS)

Septic Shock

Germany
Sanofi

Completed

A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older

Pertussis | Tetanus | Diphtheria

United States
Sanofi

Completed

Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®

Pertussis | Tetanus | Diphtheria

United States
University of Gaziantep

Completed

Effect of Cytosorb on Blood Levels of Inflammatory Biomarkers of Sepsis.

Sepsis | Cytokine Storm
CytoSorbents Europe GmbH

Withdrawn

CytoSorb® in Patients With Acute on Chronic Liver Failure (HepOnFire)

Alcoholic Hepatitis | Acute on Chronic Liver Failure

Germany
Sanofi Pasteur, a Sanofi Company

Completed

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

France, Poland
Moximed

Active, not recruiting

Calypso Knee System Clinical Study

Osteoarthritis, Knee

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Pertussis | Whooping Cough | Tetanus | Diphtheria

United States
Sanofi

Completed

Study of Adacel® Vaccine Administered to Persons 10 Years of Age

Pertussis | Tetanus | Diphtheria

United States
University Clinical Centre of Republic of Srpska

Recruiting

Population Pharmacokinetic Model of Amikacin and Vancomycin in Critically Ill Patients

Sepsis

Bosnia and Herzegovina
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents

Pertussis | Tetanus | Diphtheria

Japan
Alcon Research

Completed

Initial Performance of a Modified Daily Disposable Contact Lens

Refractive Error
Assistance Publique - Hôpitaux de Paris

Completed

The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure

Hepatitis

France
First Affiliated Hospital of Zhejiang University

Not yet recruiting

Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes
Sanofi Pasteur, a Sanofi Company

Terminated

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

Dengue Fever | Dengue Hemorrhagic Fever

Philippines
Sanofi Pasteur, a Sanofi Company

Completed

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Pertussis | Tetanus | Diphtheria | Meningitis | Meningococcal Infection | Haemophilus Influenzae Serotype b (Hib)

United States, Puerto Rico
University of Rochester

Completed

Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose

Pertussis | Whooping Cough | Tetanus | Diphtheria

United States, Canada
Sanofi Pasteur, a Sanofi Company

Completed

Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

Tetanus | Diphtheria

United States
Medical University of Vienna

Unknown

Molecular Adsorbent Recirculating System (MARS®) in Hypoxic Hepatitis (MARS in HH)

Acute Liver Failure | Hypoxic Hepatitis | Ischemic Hepatitis | Shock Liver | Hypoxic Liver Injury

Germany, Austria
Merck Sharp & Dohme LLC

Terminated

Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)

Leukemia, Lymphocytic, Acute | Myelogenous Leukemia, Acute | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myelogenous Leukemia, Chronic, Aggressive Phase
University Hospital, Geneva

Recruiting

Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines (Pertagen2x)

Pertussis | Vaccine-Preventable Diseases

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Poliomyelitis Vaccine

South Africa
Technische Universität Dresden

Recruiting

Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA) (LOLIDA)

Cardiovascular Diseases | Lipoproteinemia | Apheresis Related Complication

Germany
Astellas Pharma Inc
Toray Industries, Inc

Completed

Drug-Drug Interaction Study of TRK-100STP

Healthy

Japan
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

Meningitis | Meningococcal Disease

Korea, Republic of
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
M.D. Anderson Cancer Center
Genzyme, a Sanofi Company

Completed

Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)

Acute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome

United States
C. Babis Andreadis
GlaxoSmithKline; University of California, San Francisco

Completed

Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Diffuse Large Cell Lymphoma Relapsed/Refractory

United States
Novartis Vaccines

Completed

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Meningitis, Meningococcal

United States, Argentina, Colombia

Search clinical trials for: cytokine adsorber (CytoSorb®)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations